Skip to main content
. 2015 Dec 22;77:653–657. doi: 10.1007/s00280-015-2940-3

Fig. 1.

Fig. 1

Half-life elimination of MTX (n = 29 cycles). a Integrase-based versus NNRTI-based ARV group (p = 0.15). b TDF/FTX versus ABC/3TC ARV backbone (p = 0.68). c Elimination of MTX was not affected by eGFR (p = 0.67). d Elimination of MTX was not affected by age (p = 0.75)